T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
AZZ Inc
AZZ
$4.52B
| $52M | 0.01% |
1,241,560
-2,560
| -0.2% | -$98.7K |
|
|
ESGR
802
DELISTED
Enstar Group
ESGR
| $51.6M | 0.01% |
378,067
+56,940
| +18% | +$7.97M |
|
|
ATW
803
DELISTED
Atwood Oceanics
ATW
| $51.5M | 0.01% |
934,800
-12,000
| -1% | -$676K |
|
|
TE
804
DELISTED
TECO ENERGY INC
TE
| $51.3M | 0.01% |
3,103,325
-2,403,195
| -44% | -$41M |
|
805
Acadia Pharmaceuticals
ACAD
$4.89B
| $51.3M | 0.01% |
1,867,590
+482,390
| +35% | +$10.1M |
|
|
GNMK
806
DELISTED
GenMark Diagnostics, Inc
GNMK
| $51.2M | 0.01% |
4,213,600
+319,900
| +8% | +$3.43M |
|
807
Truist Financial
TFC
$64.7B
| $51.2M | 0.01% |
1,516,267
+202,810
| +15% | +$7.08M |
|
|
LVNTA
808
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $50.9M | 0.01% |
2,348,138
-25,641
| -1% | -$551K |
|
|
TIBX
809
DELISTED
TIBCO SOFTWARE INC
TIBX
| $50.6M | 0.01% |
1,977,980
-7,373,910
| -79% | -$176M |
|
810
VF Corp
VFC
$5.79B
| $50.5M | 0.01% |
1,077,752
+506,885
| +89% | +$23.4M |
|
|
SMRT
811
DELISTED
Stein Mart Inc
SMRT
| $50.4M | 0.01% |
3,674,667
+9,157
| +0.2% | +$123K |
|
812
Intuit
INTU
$98B
| $50.3M | 0.01% |
758,008
+7,546
| +1% | +$486K |
|
|
BEL
813
DELISTED
Belmond Ltd.
BEL
| $50.1M | 0.01% |
3,859,590
-51,130
| -1% | -$641K |
|
814
Albany International
AIN
$1.82B
| $49.7M | 0.01% |
1,385,933
-7,770
| -0.6% | -$269K |
|
815
Deere & Co
DE
$165B
| $49.6M | 0.01% |
609,021
-1,018,190
| -63% | -$84.8M |
|
|
KND
816
DELISTED
Kindred Healthcare
KND
| $49.6M | 0.01% |
3,690,810
+54,700
| +2% | +$787K |
|
817
Commerce Bancshares
CBSH
$8.61B
| $49.5M | 0.01% |
2,129,895
+231,369
| +12% | +$5.5M |
|
818
Artisan Partners
APAM
$3.03B
| $48.9M | 0.01% |
934,700
-10,700
| -1% | -$549K |
|
819
RLI Corp
RLI
$5.87B
| $48.8M | 0.01% |
2,234,080
-10,720
| -0.5% | -$220K |
|
820
Marvell Technology
MRVL
$199B
| $48.8M | 0.01% |
4,239,100
-3,215,200
| -43% | -$39.7M |
|
821
Teradyne
TER
$64.2B
| $48.7M | 0.01% |
2,945,169
+10,200
| +0.3% | +$169K |
|
|
DTV
822
DELISTED
DIRECTV COM STK (DE)
DTV
| $48.6M | 0.01% |
814,215
-676,300
| -45% | -$41.6M |
|
823
F5
FFIV
$23.6B
| $48.6M | 0.01% |
566,645
-664,200
| -54% | -$56.5M |
|
824
Chubb
CB
$133B
| $48.4M | 0.01% |
517,370
+6,300
| +1% | +$576K |
|
825
Scholastic
SCHL
$784M
| $48.4M | 0.01% |
1,688,588
+90,103
| +6% | +$2.74M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.